Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Phase 1 Completed 67 enrolled Spectrum Pharmaceuticals, Inc

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This Phase 1 study will determine the safety, tolerability, and pharmacokinetics of vinorelbine liposomes injection (VLI) in patients with advanced solid tumors, non-Hodgkin's lymphoma, or Hodgkin's disease.

Timeline

Start: 2006-07
Primary completion: 2015-06
Completion: 2015-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vinorelbine	Small molecule	—	—

Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Summary

Timeline

Drugs

Indications